Company profile for PharmaEssentia

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

PharmaEssentia Corporation aims to deliver efficacious, safe and cost-effective therapeutic products for the treatment of human diseases while aiming to bring long lasting value to our stakeholders. At PharmaEssentia, our mission is a never-ceasing commitment to the improvement of health and quality of life. PharmaEssentia was founded in 2003 by a group of Taiwanese-American executives and high-ranking scientists from leading ...
PharmaEssentia Corporation aims to deliver efficacious, safe and cost-effective therapeutic products for the treatment of human diseases while aiming to bring long lasting value to our stakeholders. At PharmaEssentia, our mission is a never-ceasing commitment to the improvement of health and quality of life. PharmaEssentia was founded in 2003 by a group of Taiwanese-American executives and high-ranking scientists from leading biotechnology and pharmaceutical companies in the US, with a goal to develop treatments for myeloproliferative neoplasms, hepatitis and other diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Taiwan
Address
Address
13F, No. 3, YuanQu Sreet, NanKang District, Taipei 115, Taiwan (Nangang Softwa...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251215883518/en/PharmaEssentia-Announces-Presentation-at-J.P.-Morgan-Healthcare-Conference-and-Strategic-Priorities-for-2026

BUSINESSWIRE
15 Dec 2025

https://www.businesswire.com/news/home/20251124044530/en/PharmaEssentia-Announces-Publication-of-Phase-3-SURPASS-ET-Results-in-The-Lancet-Haematology

BUSINESSWIRE
24 Nov 2025

https://www.businesswire.com/news/home/20251118122426/en/PharmaEssentia-Announces-Presentations-at-ASH-2025

BUSINESSWIRE
18 Nov 2025

https://www.businesswire.com/news/home/20251110427880/en/PharmaEssentia-USA-Announces-Appointment-of-Dr.-Barry-Flannelly-as-Independent-Director

BUSINESS WIRE
10 Nov 2025

https://www.businesswire.com/news/home/20250818061737/en/PharmaEssentia-to-Participate-at-Morgan-Stanley-23rd-Annual-Global-Healthcare-Conference

BUSINESSWIRE
18 Aug 2025

https://www.businesswire.com/news/home/20250603366273/en/PharmaEssentia-Announces-Presentations-at-EHA-2025-Highlighting-Clinical-Advances-in-Myeloproliferative-Neoplasms

BUSINESSWIRE
03 Jun 2025

ABOUT THIS PAGE

Contact PharmaEssentia and get a quotation

PharmaEssentia is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Gemcitabine bulk offered by PharmaEssentia

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty